Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2/3 1

Status

Completed 7Terminated 3Recruiting 3Active not recruiting 3Withdrawn 1

Sponsor Class

OTHER 17INDUSTRY 9NETWORK 3NIH 2

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3Neoplasms 1

Interventions

Radiotherapy 41Cisplatin 36Fluorouracil 17Paclitaxel 15Docetaxel 14Cyclophosphamide 14Carboplatin 14Filgrastim 13Doxorubicin 13Gemcitabine 11Etoposide 11Capecitabine 10Surgical Procedures, Operative 9Methotrexate 9Leucovorin 9Chemotherapy, Adjuvant 9Vincristine 8Peripheral Blood Stem Cell Transplantation 8Oxaliplatin 8Dexamethasone 7Bevacizumab 7Topotecan 6Radiotherapy, Conformal 6Prednisone 6Fenretinide 6Cetuximab 6Neoadjuvant Therapy 5Mitomycin 5Irinotecan 5Ifosfamide 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × NETWORK × Leuprolide × Clear all
NCT00651326 2023-08-04

DART

Canadian Cancer Trials Group

Phase 3 Terminated
48 enrolled
Genitourinary

Prostatic Neoplasms

NCT01603420 2016-03-14

External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer

Proton Collaborative Group

Phase 2/3 Terminated
2 enrolled 8 charts
Genitourinary

Neoplasms, Prostatic Neoplasms

NCT00949962 2014-07-04

Post-operative or Early Salvage XRT and ADT for High Risk PCa

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Terminated
87 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡